$EVOK this was definitely a move by a person with a large short position with 2 trading days to cover. NO one should be selling at this ridiculous low price. 32 million shares in Evoke with 3 to 4 billion established sales waiting the first year. everyone using the needle and pill form will automatically turn to the nasal spray do Gimoti. FDA already approved all trials and safe guard of the product. This will get its approval with 30 days of final submission and shoot way past the 10 dollars share mark.